OPKO Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	432.67	606.9	713.14	863.5	1,004	1,775
Revenue Growth (YoY)	-37.24%	-14.90%	-17.41%	-14.01%	-43.42%	23.64%
Cost of Revenue	372.02	401	494.63	545.37	715.98	1,193
Gross Profit	60.65	205.9	218.51	318.13	288.22	581.52
Selling, General & Admin	212.51	223	304.22	300.56	372.67	468.86
Depreciation & Amortization Expenses	77.04	77.9	82.63	86.03	87.78	50.28
Research & Development	122.42	124	105.21	89.59	73.89	76.85
Other Operating Expenses	101.58	101.6	121.49	-1.04	17.25	29.81
Total Operating Expenses	513.54	526.5	613.56	475.15	551.59	625.79
Operating Income	-101.24	-117.4	-152.07	-157.02	-226.25	18.75
Interest Income	9.32	-	8.43	3.98	1.98	0.03
Interest Expense	-92.62	-	-47.47	-13.51	-12.06	-18.88
Other Non-Operating Income (Expense)	-163.5	-124	322.45	-45.07	-320.46	-46.7
Total Non-Operating Income (Expense)	-246.81	-124	283.41	-54.6	-330.54	-65.55
Pretax Income	-348.05	-241.4	131.34	-211.62	-556.79	-46.8
Provision for Income Taxes	-16.09	-15.7	42.84	4.44	-63.5	15.49
Net Income	-212.96	-225.7	-53.22	-188.86	-328.41	-30.14
Net Income to Common	-212.96	-225.7	-53.22	-188.86	-328.41	-30.14
Shares Outstanding (Basic)	772	751	694	752	719	648
Shares Outstanding (Diluted)	773	751	594	752	719	648
Shares Change (YoY)	-6.83%	26.45%	-20.98%	4.55%	10.95%	1.16%
EPS (Basic)	-0.27	-0.30	-0.08	-0.25	-0.46	-0.05
EPS (Diluted)	-0.27	-0.30	-0.08	-0.25	-0.46	-0.05
Free Cash Flow	-	0	-208.5	-44.47	-119.77	6.18
Free Cash Flow Growth	-	-	-	-	-	6.68%
Free Cash Flow Per Share	-	-	-0.35	-0.06	-0.17	0.01
Gross Margin	14.02%	33.93%	30.64%	36.84%	28.70%	32.77%
Operating Margin	-23.40%	-19.34%	-21.32%	-18.18%	-22.53%	1.06%
Profit Margin	-49.22%	-37.19%	-7.46%	-21.87%	-32.70%	-1.70%
FCF Margin	-	0.00%	-29.24%	-5.15%	-11.93%	0.35%
EBITDA	-101.24	-117.4	-53.89	-51.72	-117.6	97.47
EBITDA Margin	-23.40%	-19.34%	-7.56%	-5.99%	-11.71%	5.49%
EBIT	-101.24	-117.4	-152.07	-157.02	-226.25	18.75
EBIT Margin	-23.40%	-19.34%	-21.32%	-18.18%	-22.53%	1.06%
Effective Tax Rate	4.74%	6.50%	32.62%	-2.10%	11.40%	-33.10%

SEC Filings: 10-K · 10-Q